Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 4:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1081–1104 of 8,689 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Heart Failure
Interventions: Ruboxistaurin; Drug
Lead sponsor: University of Tennessee; Other
Eligibility: 30 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Breast Cancer, Insomnia
Interventions: PROSPECT; Behavioral
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Arteriovenous Fistula
Interventions: AV Fistula creation with sutures, AV Fistula creation with clips; Device
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 3
States / cities: Tampa, Florida

Conditions: Stress Disorders, Post-Traumatic
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 817 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2027
U.S. locations: 4
States / cities: West Haven, Connecticut • Boston, Massachusetts • Seattle, Washington

Conditions: Epilepsy (Treatment Refractory)
Interventions: Seizure risk forecast, Control seizure risk forecast; Other
Lead sponsor: Insel Gruppe AG, University Hospital Bern; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis
Interventions: Active NMES; Device
Lead sponsor: CyMedica Orthopedics, Inc; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Nonconvulsive Seizures
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Vaginitis, Vulvar Diseases
Interventions: Vaginitis panel; Diagnostic Test
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older · Female only
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions: MammaPrint; Device
Lead sponsor: Agendia; Industry
Eligibility: 18 Years to 90 Years · Female only
Enrollment: 820 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 53
States / cities: Phoenix, Arizona • Burbank, California • Palm Springs, California + 47 more

Conditions: Contraception
Interventions: Paragard® T380A Intrauterine Copper Contraceptive with New Inserter; Combination Product
Lead sponsor: CooperSurgical Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 119 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 8
States / cities: Denver, Colorado • South Miami, Florida • Atlanta, Georgia + 4 more

Conditions: Regional Anesthesia, Horner Syndrome, Cerebral Blood Flow
Interventions: TCD Measurement; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: Breast Cancer
Interventions: Bevacizumab, Docetaxel, Trastuzumab; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Hip Osteoarthritis, Rheumatoid Arthritis, Joint Diseases, Avascular Necrosis, Dislocation, Hip, Femoral Neck Fractures, Trochanteric Fractures, Revision Surgeries
Interventions: G7 Dual Mobility with Vivacit-E bearing, G7 Dual Mobility Longevity bearing; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 358 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2037
U.S. locations: 6
States / cities: Little Rock, Arkansas • Denver, Colorado • Jersey City, New Jersey + 3 more

Conditions: Hypertension
Interventions: MobiusHD™; Device
Lead sponsor: Vascular Dynamics, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 7
States / cities: Birmingham, Alabama • Atlanta, Georgia • Des Moines, Iowa + 4 more

Conditions: Bladder Cancer
Interventions: standard fluid management, fluid management guided by the EV1000; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 5
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Commack, New York + 2 more

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: simvastatin, Placebo; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 40 Years to 80 Years
Enrollment: 885 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 35
States / cities: Birmingham, Alabama • Los Angeles, California • San Francisco, California + 26 more

Conditions: Obesity, Bariatric Surgery Candidate, Hypertension, Diabetes
Interventions: Magnetically Controlled Capsule Endoscopy (MCCE); Device
Lead sponsor: Jerry Dang; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Heart Failure
Interventions: V-LAP™ SYSTEM; Device
Lead sponsor: Vectorious Medical Technologies Ltd.; Industry
Eligibility: 22 Years to 88 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Esophageal Cancer
Interventions: Not listed
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2005
U.S. locations: 44
States / cities: Birmingham, Alabama • La Jolla, California • San Francisco, California + 28 more

Conditions: Carpometacarpal Thumb Arthritis
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Intubation;Difficult
Interventions: Red Rubber Catheter, Standard nasal tracheal Intubation; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 2
States / cities: Dallas, Texas • Houston, Texas

Conditions: Prostate Cancer
Interventions: Docetaxel, Doxorubicin hydrochloride, Estramustine phosphate sodium, Ketoconazole, Prednisone, Vinblastine, Strontium chloride Sr 89, Dexamethasone; Drug · Radiation
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 265 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 40
States / cities: Gainesville, Georgia • Savannah, Georgia • Hines, Illinois + 23 more

Conditions: Scoliosis
Interventions: Chewing gum, Control; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 10 Years to 18 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Wound; Head, Multiple, Wound; Head, Scalp, Wound; Head, Wound Infection, Wound Complication, Wound Dehiscence, Wound of Skin, Wound Open, Wounds, Penetrating, Wounds, Nonpenetrating, Wounds and Injuries, Wounds, Disturbance of Wound Healing, Facial Bones Fracture, Soft Tissue Injuries, Skull Fractures, Surgical Wound, Surgical Wound Infection, Wound Healing
Interventions: Not listed
Lead sponsor: Dufresne, Craig, MD, PC; Other
Eligibility: Not listed
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Fairfax, Virginia

Search by objective public record fields.

Ruboxistaurin in New York Heart Failure Classification III-IV Patients

Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast Cancer

Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation

Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study

Epilepsy Cycles Longitudinal Monitoring to Inform Personalized Seizure-risk Estimation (ECLIPSE)

Evaluation of NMES for Reducing Pain and Improving Functional Outcomes in Knee OA Patients

Nonconvulsive Seizure Identification on Quantitative EEG by Neuro ICU Nurses

Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)

Cerebral Blood Flow Evaluation With Trancranial Doppler After Interscalene Nerve Block

Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer

G7 Dual Mobility With Vivacit-E or Longevity PMCF

Controlling and Lowering Blood Pressure With The MOBIUSHD™

A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy

Simvastatin Therapy for Moderate and Severe COPD

Preoperative Use of a Magnetically Controlled Capsule Endoscopy in Patients Undergoing Bariatric Surgery

A Multi-center, National, Open-label, Prospective Study to Evaluate the Performance of the V-Lap™ System

Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]

CMC Arthritis - Neoprene Vs. Thermoplast Short Opponens Splinting

Red-Rubber Catheter to Facilitate Nasotracheal Intubation in Adult Patients

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Chewing Gum Facilitates an Earlier Return to Bowel Function in Pediatric Scoliosis Patients: A Prospective Randomized Study

Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds